ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 188,49
-0,63%
Dow Jones
39 869,38
-0,10%
DAX
18 738,81
-0,72%
Brent Oil
83,205
0,00%
Bitcoin
65 306,08
0,10%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Longeveron Inc (LGVN)

  7. Longeveron Inc (LGVN) Actualités

LGVN

Longeveron (LGVN)

Longeveron Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:LGVN
DateHeureSourceTitreSymboleSociété
14/05/202422h05GlobeNewswire Inc.Longeveron Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LGVNLongeveron Inc
10/05/202422h05GlobeNewswire Inc.Longeveron Announces Board of Directors Planned TransitionsNASDAQ:LGVNLongeveron Inc
02/05/202414h03GlobeNewswire Inc.Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024NASDAQ:LGVNLongeveron Inc
25/04/202422h05GlobeNewswire Inc.Longeveron to Present at the Planet MicroCap ShowcaseNASDAQ:LGVNLongeveron Inc
18/04/202422h05GlobeNewswire Inc.Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public OfferingNASDAQ:LGVNLongeveron Inc
17/04/202414h00GlobeNewswire Inc.Longeveron Announces Exercise of Warrants for $6.2 Million Gross ProceedsNASDAQ:LGVNLongeveron Inc
15/04/202414h30GlobeNewswire Inc.Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)NASDAQ:LGVNLongeveron Inc
11/04/202423h17GlobeNewswire Inc.Longeveron Announces Closing of $5.2 Million Public OfferingNASDAQ:LGVNLongeveron Inc
08/04/202420h15GlobeNewswire Inc.Longeveron Announces Pricing of $5.25 Million Public OfferingNASDAQ:LGVNLongeveron Inc
08/04/202414h30GlobeNewswire Inc.Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and GoalsNASDAQ:LGVNLongeveron Inc
14/11/202314h17GlobeNewswire Inc.IBN Announces Latest Episode of The Bell2Bell Podcast featuring Wa’el Hashad, CEO of Longeveron Inc.NASDAQ:LGVNLongeveron Inc
07/09/202314h30GlobeNewswire Inc.IBN Coverage Initiated for Longeveron Inc.NASDAQ:LGVNLongeveron Inc
06/09/202323h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGVNLongeveron Inc
18/08/202322h34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LGVNLongeveron Inc
16/08/202319h21Edgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingNASDAQ:LGVNLongeveron Inc
14/08/202322h55Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NASDAQ:LGVNLongeveron Inc
14/08/202322h45Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LGVNLongeveron Inc
11/08/202322h31Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:LGVNLongeveron Inc
11/08/202314h58Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LGVNLongeveron Inc
02/08/202323h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LGVNLongeveron Inc
26/06/202322h37Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:LGVNLongeveron Inc
12/06/202323h01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:LGVNLongeveron Inc
12/06/202322h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LGVNLongeveron Inc
09/06/202323h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LGVNLongeveron Inc
12/05/202322h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LGVNLongeveron Inc
12/05/202314h00GlobeNewswire Inc.Longeveron Inc. Provides Corporate Update and Reports First Quarter 2023 Financial ResultsNASDAQ:LGVNLongeveron Inc
09/05/202314h30GlobeNewswire Inc.Longeveron Announces New Long-Term Survival Data from ELPIS I Trial of Lomecel-B™ for Hypoplastic Left Heart SyndromeNASDAQ:LGVNLongeveron Inc
28/04/202322h14Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:LGVNLongeveron Inc
28/04/202322h07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:LGVNLongeveron Inc
19/04/202314h59GlobeNewswire Inc.Longeveron Announces First Patient Dosed in Phase 2 Clinical Trial of Lomecel-B™ for Aging-Related Frailty in JapanNASDAQ:LGVNLongeveron Inc
 Showing the most relevant articles for your search:NASDAQ:LGVN

Dernières Valeurs Consultées

EU
AI
Air Liquide
EU
ACA
Credit Agricole
EU
GLE
Societe Generale
EU
VK
Vallourec
EU
EN
Bouygues
NASDAQ
MSFT
Microsoft
EU
HO
Thales
EU
ML
Michelin
SPI
SP500
S&P 500
EU
DG
Vinci
NASDAQ
AMZN
Amazon.com
EU
CAP
Capgemini
COIN
ETHUSD
Ethereum
NYSE
JPM
JP Morgan Chase
EU
AF
Air FranceKLM
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés